Výsledky vyhledávání - "JISHA MOHANAN"

IMPLEMENTING CENTRAL COMPOSITE DESIGN FOR THE DEVELOPMENT OF TACROLIMUS FILM FOR SUBLINGUAL ADMINISTRATION

Autor: JISHA MOHANAN, GOPINATH SUBRAMANIYAN, ARUL KUTTALINGAM, DAMODHARAN NARAYANASAMY

Publikováno v: International Journal of Applied Pharmaceutics. :35-42

Objective: The study aimed to develop fast-dissolving films (FDFs) of the immunosuppressant drug tacrolimus monohydrate for sublingual administration, employing central composite design (CCD), to improve its bioavailability. Methods: Tacrolimus: β-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ea4c201a90637ab982454814049d4ca
https://doi.org/10.22159/ijap.2023v15i3.47265

Zobrazit plný text záznamu

DEVELOPMENT OF NANO BASED FILM FORMING GEL FOR PROLONGED DERMAL DELIVERY OF LULICONAZOLE

Autor: T. K. SUBAIR, JISHA MOHANAN

Publikováno v: International Journal of Pharmacy and Pharmaceutical Sciences. :31-41

Objective: Luliconazole (LZL) has low aqueous solubility that limits its dermal bioavailability and acts as a barrier to topical delivery. The conventional topical formulations have a limited ability to retain the drug over the skin for a prolonged p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b8b0fe78947454fd5c56446cd932156
https://doi.org/10.22159/ijpps.2022v14i2.43253

Zobrazit plný text záznamu

DEVELOPMENT OF NANOPARTICLES SUSPENSION FOR PAEDIATRIC DRUG ADMINISTRATION

Autor: K. K. RAJULA, JISHA MOHANAN

Publikováno v: International Journal of Pharmacy and Pharmaceutical Sciences. :52-61

Objective: Enalapril maleate (EM) is an angiotensin-converting enzyme (ACE) inhibitor. It is generally prescribed for the treatment of hypertension, heart failure and chronic kidney diseases in adults and children. EM 2.5 mg, 5 mg, 10 mg and 20 mg ta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::57ddca278c9cf591921eaea71dbd09b7
https://doi.org/10.22159/ijpps.2022v14i2.43529

Zobrazit plný text záznamu

DEVELOPMENT AND CHARACTERIZATION OF TACROLIMUS TABLET FORMULATIONS FOR SUBLINGUAL ADMINISTRATION

Autor: Damodharan Narayanasamy, Jisha Mohanan, Seenivasan Palanichamy, Arul Kuttalingam

Publikováno v: International Journal of Applied Pharmaceutics. :89-97

Objective: The study aimed to prepare and characterize inclusion complexes of tacrolimus with β-cyclodextrin to improve its solubility and to formulate them into sublingual fast disintegrating tablets with a view to bypass the first-pass metabolism.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2f57de9577d12ef1fd1b5c52e4fb0e6
https://doi.org/10.22159/ijap.2021v13i6.42429

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání